ofatumumab   Click here for help

GtoPdb Ligand ID: 6778

Synonyms: Arzerra® | GSK 1841157 | GSK1841157 | humax-CD20 | Kesimpta® (subcutaneous) | OMB-157 | OMB157
Approved drug Immunopharmacology Ligand
ofatumumab is an approved drug (FDA (2009), EMA (2010))
Compound class: Antibody
Comment: Ofatumumab is a type I anti-CD20 monoclonal, designed to target surface CD20 on B-lymphocytes.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: ofatumumab

Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2009), EMA (2010))
International Nonproprietary Names Click here for help
INN number INN
8606 ofatumumab
Synonyms Click here for help
Arzerra® | GSK 1841157 | GSK1841157 | humax-CD20 | Kesimpta® (subcutaneous) | OMB-157 | OMB157
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 194
Other databases
GtoPdb PubChem SID 178103384
PubChem SID 178103384
Search PubMed clinical trials ofatumumab
Search PubMed titles ofatumumab
Search PubMed titles/abstracts ofatumumab
Wikipedia Ofatumumab